Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 7 Next »

Author

  • Christine Maggiore

Publisher

  • -

Category

  • AIDS Defining Illness

Topic

  • AIDS Paradox

  • AIDS Dilemma

  • AIDS Definitions

  • HIV Antibody

  • AIDS Epidemiology

  • C.D.C.

Article Type

  • Editorial article

Publish Year

  • 1996

Meta Description

  • AIDS, not a new disease, is a term by CDC for 29 known illnesses occurring in HIV positive individuals. CDC's AIDS definitions have expanded thrice since 1981.

Summary

  • AIDS is not a new disease but a term given by the Centers for Disease Control (CDC) to a collection of 29 known illnesses that occur in individuals who test positive for HIV. The definition of AIDS in America has been expanded three times since 1981, causing significant increases in the number of new AIDS cases. However, the conditions that are called AIDS vary from country to country. For instance, Canada's Laboratory Centre for Disease Control does not recognize the American T cell count criteria for AIDS. This means that over 25% of all people in the US diagnosed with AIDS would not have AIDS if they were in Canada. The CDC has previously raised public concern over relatively insignificant health matters, such as the Swine Flu and Legionnaire's Disease.

Meta Tag

  • AIDS

  • Disease

  • CDC

  • Definitions

  • HIV

  • Antibodies

  • Illnesses

  • Symptoms

  • Diagnosis

  • Health

  • Infections

  • Epidemics

Featured Image

Featured Image Alt Tag

  • Keyword of the image

By Christine Maggiore
This is a chapter from the book
What if everything you thought about AIDS was wrong?
www.aliveandwell.org

Contrary to popular belief, AIDS is not new and is not a disease.

AIDS is a new name given by the Centers for Disease Control (CDC) to a collection of 29 familiar illnesses and conditions including yeast infection, herpes, diarrhea, some pneumonias, certain cancers, salmonella, and tuberculosis. (1) These illnesses are called AIDS only when they occur in a person who also has protective disease fighting proteins or antibodies that are thought to be associated with HIV.

A person is diagnosed with AIDS if they have one or more of the 29 official AIDS-defining conditions and if they also testpositive for antibodies associated with HIV. In other words, pneumonia in a person who tests HIV positive is AIDS, while the same pneumonia in a person testing HIV negative is pneumonia. The clinical manifestations and symptoms of the pneumonia may be identical, but one is called AIDS while the other is just called pneumonia.

None of the 29 AIDS illnesses are new, none appear exclusively in people who test positive for HIV antibodies, and all have documented causes and treatments that are unrelated to HIV. Prior to the CDC's creation of the AIDS category, these 29 old diseases and conditions were not thought to have a single, common cause.

Although most of us associate AIDS with severe illness, on January 1, 1993, the CDC expanded the definition of AIDS to include people with a T cell count of 200 or less who have no illness or symptoms. (2) This new definition caused the number of AIDS cases in America to double overnight. (3) Since 1993, more than half of all new AIDS cases diagnosed each year have been among people who have no clinical symptoms or disease. (4)

It is only through expansions of the AIDS definition that the number of new AIDS cases has grown. The definition of AIDS in America has been expanded three times since 1981. Although each addition to the definition has caused significant increases in the number of new AIDS cases, AIDS had leveled off in all risk groups by 1992 and has been declining steadily since the second quarter of 1993.

If the CDC had continued to use the first three definitions of AIDS, new American AIDS cases for 1997 would have totaled just over 10,000, making AIDS a relatively insignificant health problem. Using the 1993 definition, 21,000 new cases of AIDS were added to the year's total, and of these, more than 20,000 cases were counted among people with no symptoms or illness. (5)

In 1998, the CDC ceased providing information on what AIDS diseases or definitions qualify people for an AIDS diagnosis each year. This means that the public will no longer know how many new AIDS cases are diagnosed in people who are not ill. (6)

Another surprising fact is that you can receive a diagnosis of AIDS without ever having an HIV test. This is referred to as a "presumptive diagnosis." According to CDC records, more than 62,000 American AIDS cases have been diagnosed with no HIV test. (7) Even though the only difference between "pneumonia" and "AIDS" is a positive HIV test, the test is not required for a diagnosis of AIDS.

Since AIDS is not a disease, and there is no single, universally accepted definition for AIDS, the conditions that are called AIDS vary from country to country. For example, Canada's Laboratory Centre for Disease Control (LCDC) does not recognize the American T cell count criteria for AIDS. (8) This means that 182,200 American AIDS patients -- more than 25% of all people in the US ever diagnosed with AIDS -- would not have AIDS if they were in Canada.

The World Health Organization (WHO) employs two distinctly different definitions for AIDS in Africa, neither of which conform to the criteria for American AIDS or Canadian AIDS. The diagnostic definition most commonly used in Africa does not require an HIV test, only that a patient have at least one of three major clinical symptoms (weight loss, fever and/or cough), plus one "minor sign" such as generalized itching or swollen glands. (10)

Before bringing us AIDS, the CDC attempted to sound similar alarms over relatively insignificant health matters. In 1976, after five soldiers stationed at a military base in New Jersey contracted the flu, CDC officials announced an imminent influenza epidemic. Their news releases predicted an outbreak that could wipe out as many as 500,000 Americans within a year. Congress responded to the CDC warnings by diverting millions of federal dollars into an emergency vaccine program, and following appeals from US President Gerald Ford, multitudes of concerned Americans received Swine Flu shots. However, no epidemic ever materialized and no substantiation for the notion of a life-threatening pig virus was ever found. Instead, more than 600 people were left paralyzed by the vaccine which also caused nearly 100 deaths. (11)

The CDC raised public concern again the next year with harrowing predictions for Legionnaire's Disease. Following massive government research efforts and relentless media reports of a new contagious disease, the form of common pneumonia dubbed "Legionnaire's" ended up taking the lives of less than 30 people nationwide. It was later discovered that 20 to 30 percent of Americans are positive for the Legionella bacteria, a common microbe found in water systems throughout the country. (12) The CDC's preoccupation with contagious illness contrasts with the fact that all infectious diseases combined take the lives of less than 1% of modern day Americans. (13)

Defined Terms

AIDS: Acquired Immune Deficiency Syndrome.
Antibodies: Proteins that are manufactured by lymphocytes (a type of white blood cell) to neutralize an antigen (foreign protein) in the body. Bacteria, viruses and other microorganisms commonly contain many antigens; antibodies formed against these antigens help the body neutralize or destroy the invading microbe. Antibodies may also be formed in response to vaccines.
HIV: Human Immunodeficiency Virus; the alleged cause of AIDS.
T cell: One of the two main classes of lymphocytes. T cells play an important role in the body's immune system.
Virus: An organism comprised mainly of genetic material within a protein coat. Depending on the type of virus, the nucleic acid may be either DNA or RNA; in retroviruses, the nucleic acid is RNA. Viruses are incapable of activities typical of life such as growth, respiration and metabolism. Outside living cells, viruses are wholly inert.
Microbe: A minute form of life; a microorganism, especially one that causes disease.

References

 Click here to expand..
All referenced text is excerpted from the 4th edition (second printing) of the book What If Everything You Thought You Knew About AIDS Was Wrong? and wherever possible, has been updated for this web site.

  1. In the United States, AIDS = 28 old illnesses and one non-illness:

  2. 1983 original AIDS definition (12 illnesses): Pneumocystis carinii pneumonia, Kaposi's sarcoma, toxoplasmosis, strongyloidosis, aspergillosis, cryptococcosis, candidiasis, cryptosporidiosis, cytomegalovirus, herpes simplex, progressive multifocal leukoencephalopathy, lymphoma of the brain

  3. 1985 revised definition (seven more old illnesses added): Mycobacterium avium complex, histoplasmosis, isosporiasis, Burkitt's lymphoma, immunoblastic lymphoma, candidiasis of the bronchi, trachea and lungs, and a positive HIV antibody test.

  4. 1987 revised definition (six additional illnesses): Encephalopathy, Mycobacterium tuberculosis, wasting syndrome, coccidioidomycosis, cytomegalovirus retinitis, Salmonella septicemia. HIV antibody test no longer required.

  5. 1993 revised definition (three more illnesses plus one surrogate marker): Recurrent bacterial pneumonia, invasive cervical cancer, pulmonary tuberculosis, T Cell count of <200 or <14% of total lymphocytes (non-illness).

  6. Source: Duesberg P, Yiamouyannis J, 1995 AIDS: The Good News Is HIV Doesn't Cause It Health Action Press

  7. US Centers for Disease Control 1994 HIV/AIDS Surveillance Report Year-end edition 1993

  8. Navarro M AIDS Definition Widened to Include Blood Cell Count August 8 1993 New York Times; Altman L AIDS Cases Increase Among Heterosexuals March 11 1994 New York Times

  9. US Centers for Disease Control HIV/AIDS Surveillance Report Year-end editions 1998, 1997, 1996, 1995, 1994, 1993

  10. US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end edition 1997 Table11 p17

  11. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end edition 1998 p43

  12. Duesberg P 1993 The HIV Gap in National Statistics Bio/Technology 11:955-6

  13. Laboratory Centre for Disease Control, Health Canada, 1998 HIV and AIDS in Canada: Surveillance Report to December 31, 1997; US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998

  14. US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end edition 1997 Figure 6 p25; US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end edition 1998

  15. World Health Organization 1985 Bangui definition for AIDS in Africa (current use confirmed by WHO April 1999); WHO case definitions for AIDS surveillance in adults and adolescents, Weekly Epidemiological Record September 1994; 69:273-80 (current use confirmed by WHO April 1999)

  16. Duesberg P 1996 Inventing the AIDS Virus: Regnery Press, Washington DC p141-145

  17. Duesberg P 1996 Inventing the AIDS Virus: Regnery Press, Washington DC p54-58

  18. Carins J 1978 Cancer: Science and Society WH Freeman and Company, San Francisco

  19. Duesberg P, Rasnick D 1998 The AIDS Dilemma: Drug Diseases Blamed on a Passenger Virus Genetica 104:85-132; Mullis K 1998 Dancing Naked in the Mindfield Pantheon Books, New York p171-190; Shenton J 1998 Positively False St Martin's Press, New York p6-17

  20. Mullis K 1988 Dancing Naked in the Mindfield Pantheon Books, New York p 178; Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington DC p 89-96

  21. Altman L New York Times, April 23 1984

  22. Altman L Researchers Believe AIDS Virus is Found New York Times, April 24 1984 (Dr. James Curran, head of the CDC's AIDS investigating team, calls discovery "the virus that causes AIDS") 

  23. Gallo found HIV in only 26 of 63 AIDS patients (41%) Source: Gallo R May 4 1984 Science Volume 224 p502

  24. In 1983, Montagnier sent Gallo "retrovirus particles" (LAV) taken from the lymph node of a male homosexual without AIDS. Source: Science May 20 1983, Vol 220; the virus Gallo claimed to have discovered in 1984 was found to actually be Montagnier's LAV. Source: New Scientist, February 12 1987

  25. Dingell J Misconduct in Medical Research, New England Journal of Medicine 1993 328:1610-1615; Co-Discoverer of HIV Loses Bid to Regain Job AIDS Policy and Law May 14 1999 Vol 14 No 9; Crewdson J In Gallo Case, Truth Termed a Casualty: Science Subverted in AIDS Research Chicago Tribune, January 1 1995

  26. Baffour A Are 26 Million Africans Dying of AIDS? December 1998 New African Magazine p34-42

  27. Duesberg P Inventing the AIDS Virus Regnery Press, Washington DC; Root-Bernstein R 1993 Rethinking AIDS The Free Press, New York

  28. Cordes R, et al 1995 Pitfalls in HIV Testing Postgraduate Medicine 98:177; Langedijk J, et al 1992 Identification of Cross-reaction Epitopes Recognized by HIV-1 False-positive Sera AIDS 6:1547-1548; Strandstrom H, et al 1990 Studies with Canine Sera that Contain Antibodies which Recognize HIV Structural Proteins Cancer Research, September 1:50(17 Suppl):56285-56305; Germanson T 1989 Screening for HIV: Can We Afford the Confusion of the False Positive Rate? Journal of Clinical Epidemiology 42:1235; Weiss R, et al 1988 HIV Testing is the Answer-What's the Question? New England Journal of Medicine 319:1010-1012; Burke, et al 1988 Measurement of the False Positive Rate in a Screening Program for HIV Infections New England Journal of Medicine 319(15):961-964; US News and World Report, November 23 1987 p22c; Jackson G, et al 1988 Passive Immunoneutralisation of Human Immuno-deficiency Virus in Patients with Advanced AIDS Lancet, September 17:647

  29. Papadopulos-Eleopulos E, et al 1993 Is a Positive Western Blot Proof of HIV Infection? Bio/Technology Journal Vol 11 p696-707

  30. Papadopulos-Eleopulos E, et al 1993 Has Gallo Proven the Role of HIV in AIDS? Emergency Medicine 5:113-123

  31. Papadopulos-Eleopulous E, et al 1993 Is a Positive Western Blot Proof of HIV Infection? Bio/Technology Vol. 11

  32. Strandstrom H, et al 1990 Studies with Canine Sera which Recognise HIV Structural Proteins, Cancer Research 50:5628s-5630s. Source: Testing, Testing, 1,2,3... Turner V 1996 Contiuum Vol 3:5 p8-11

  33. Papadopolus-Eleopulos E, et al 1993 Is a Positive Western Blot Proof of HIV Infection? Bio/Technology Journal Vol 11 p696-701; Quantum Clinical Laboratory, Los Angeles, CA: HIV antibody test results for Christine Maggiore April 9 1992 HIV reactive, WB positive positive; March 27 1993 HIV reactive, WB indeterminate; September 1 1993 HIV non-reactive

  34. Abbott Laboratory's ELISA HIV antibody test kit pamphlet

  35. Continuum Vol 3:4 with thanks to Val Turner, Royal Perth Hospital, Australia; Bio/Technology June 1993 11:696-707

  36. Roche Amplicor PCR Diagnostics HIV-1 Monitor test kit pamphlet

  37. Curran J 1985 The Epidemiology of AIDS: Current Status and Future Prospects Science 229:1352-1357; Karon, et al 1996 Prevalence of HIV Infections in the US Journal of the American Medical Association 276:126-131; Krieger L One in 300 US Adults Infected, San Francisco Examiner July 7 1996 pA82

  38. NBC Nightly News, March 10 1995: Robert Hager of NBC reported that the CDC was about to lower estimates they knew were too high. CDC spokesperson Michelle Bond remarked that the CDC officials were reluctant to report lower numbers for fear of adverse budgetary consequences.

  39. All STDs except genital herpes: US Centers for Disease Control 1997, Table 1: Cases of STDs reported by state health departments in US 1941-1997, STD Surveillance p65-66. Genital herpes: Meyer T March 24 1998 Associated Press, Atlanta (Meyer quotes CDC and Dr. Charles Bell of Texas Department of Health)

  40. US Centers for Disease Control 2003 HIV/AIDS Surveillance Report Year-end edition 2002 (Deaths in persons with AIDS, cumulative totals through December 2002)

  41. US Centers for Disease Control HIV/AIDS Surveillance Report Year-end edition states "Reported deaths are not necessarily caused by HIV-related disease"

  42. CDC Wonder website; The New York Times, death count, all ages, all races, both genders 1981-2002

  43. Lazarou J, et al 1998 Incidence of Adverse Drug Reactions in Hospitalized Patients (1966-1996) Journal of the American Medical Association, 279:1200; Manmaney T Medications Kill 100,000 Annually Los Angeles Times April 15 1998; CDC Wonder website 2004

  44. PBS 1998 The American Experience: Influenza 1918

  45. World Health Organization Weekly Epidemiological Record November 2001 (current)

  46. UNAIDS June 1998 Report on the Global Epidemic; World Health Organization June 1998, Weekly Epidemiological Record

  47. CDC National Vital Statistics Report October 7 1998, Vol 47:4 Table E p7 (Deaths and death rates, final 1996 and preliminary 1997)

  48. Geshekter C 1997 AIDS: The Leading Cause of Unjustified Hysteria, Reappraising AIDS, February Vol 5:2

  49. Institute of Medicine (IOM) 1996 Scientific Opportunities and Public Needs; Webster K Disproportionate Funding Associated Press June 16 1999

  50. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end edition 1998

  51. Crowne D, et al 1964 The Approval Motive John Wiley and Sons, New York; Saxe L 1991 Lying: Thoughts of an Applied Social Psychologist American Psychologist 46:409-415; Source: Brody S Sex at Risk Transaction Publishers, New Brunswick

  52. Brody, S 1997 Sex at Risk Transaction Publishers, New Brunswick; 80%: Potterat, et al 1987 JAMA 256 p 12; 65%: Renzullo, et al 1990 JAIDS 3, p266-271; 83%-90%: Committee on AIDS Research and the Behavioral, Social, and Statistical Sciences 1989; 69%: Chicago Dept of Public Health, Journal of AIDS 1997; 99.4%: NYC Dept of Health, American Journal of Epidemiology 137:2

  53. Figures for AIDS by Risk Groups are based on cumulative figures through 1998 and do not include cases where risk status was not assessed; AIDS by Health Status are for years 1993 through 1997 using Table 11 of the 93-97 US CDC HIV/AIDS Surveillance Reports (1997 was the last year the CDC published the data in Table 11); AIDS by Gender is based on cumulative figures through 1998

  54. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998

  55. Burke D, et al 1990 Seroprevalence Among Applicants for US Military Service Unpublished data through 1997 from US Military Processing: For a copy of this unpublished data, send a SASE to the author

  56. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998 p26

  57. Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington DC p183

  58. Holding R, Carlsen W 1998 Epidemic Ravages Caregivers San Francisco Chronicle p1, A6-A8

  59. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998 Table 7 p14; US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end 1997 Table 8 p15

  60. Laboratory Centre for Disease Control, Health Canada, April 1998 Gonorrhea in Canada; US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end 1997, Tables 13A and 13B; Interview with LCDC Bureau of AIDS and STDs Office of Don Sutherland, September 14, 1998: Gonorrhea cases in Canada

  61. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998 Table 7 p14; US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end 1997 Table 8 p15

  62. Mok, et al 1987 Infants born to Mothers Seropositive for HIV Lancet 1164-1168; European Collaborative Study 1991 Children Born to Women with HIV 1 Lancet 337:253-260

  63. Source: National Center for Health Statistics July 1996 703/821-8955: Cumulative SIDS deaths in children under 1 year of age 1983-1996, 1997 preliminary, 1981-1982 computed by average of years 1983-1993

  64. Transactions of the Society of Actuaries, Vol XLIV p333-97; Boffey P April 22 1988, Researchers List Odds of Getting AIDS in Heterosexual Intercourse New York Times; Hearst N, Hulley S April 1988 Journal of the American Medical Association; Dangers Real and Imagined December 8 1997 Wall Street Journal; Discover magazine, May 1996 p82

  65. World Health Organization, November 1998 Weekly Epidemiological Record (current)

  66. Harvard University Global Burden of Disease Study, 1996; World Health Organization, Geneva 1996 Fighting Disease, Fostering Development; Geshekter C Rethinking AIDS in Africa Reappraising AIDS Vol 3:2 February 1995

  67. World Health Organization 1985 Bangui definition for AIDS in Africa (in current use); WHO case definitions for AIDS surveillance in adults and adolescents Weekly Epidemiological Record September 1994 69:273-80 (confirmed April 1999 by WHO)

  68. World Health Organization, November 1998 Weekly Epidemiological Record (current); Harvard University Global Burden of Disease Study, 1996; World Health Organization, Geneva 1996 Fighting Disease, Fostering Development; Geshekter C Rethinking AIDS in Africa Reappraising AIDS Vol 3:2 February 1995; World Health Organization 1985 Bangui definition for AIDS in Africa (in current use); WHO case definitions for AIDS surveillance in adults and adolescents Weekly Epidemiological Record September 1994 69:273-80 (confirmed April 1999 by WHO); World Health Organization World Health Report 1998 Annual cases of selected diseases

  69. Kestler H, et al 1990 Induction of AIDS in Rhesus Monkey by Molecularly Cloned SIV Science 2448:1109-112; Kestler, et al 1991 Importance of Net Gene for Maintenance of High Virus Loads Cell 65:651-662; Fultz, et al 1990 Humoral Response to SIV/SMM Infection in Macaque and Mangabey Monkeys Journal of AIDS 3:319-329; Weiss R, et al 1985 Molecular Biology of RNA Tumor Viruses Cold Spring Harbor Press, New York; Blatner W, et al 1988 HIV Causes AIDS Science 241:514-515; Lambrou E 1994 AIDS Scare or Scam p14-15 Vantage Press, New York

  70. Gao, et al Nature February 4 1999

  71. World Health Organization, November 1998 Weekly Epidemiological Record (current)

  72. Russell R Kenya Slow to Face Up to AIDS Scourge Reuters November 25 1998

  73. World Health Organization World Health Report 1998

  74. World Health Organization World Health Report 1998 Annual cases of selected diseases

  75. Journal of AIDS 1994 7:8 p876

  76. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998; 9(2) Calculations: David Crowe, Alberta Reappraising AIDS Society

  77. US Centers for Disease Control HIV/AIDS Surveillance Report Year-end editions 1997, 1996, 1995, 1994, 1993 (AIDS indicator conditions reported by age group, United States)

  78. US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end 1997 p25 Figure 6

  79. US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end 1997 p25 Figure 6

  80. POZ magazine July 1999: Glaxo-Wellcome Ad for Ziagen (abacavir sulfate), December 1998 MG-001; Merck Ad for Crixivan (indinavir) Merck and Co, Inc. 1998 99-4084; Roxanne Ad for Viramune (nevirapine) July 1999, RX-2140 (4/98); Glaxo-Wellcome Ad for Combivir (lamivudine/zidovudine) March 1999

  81. POZ magazine July 1999: Glaxo-Wellcome Ad for Combivir

  82. Hammer S, et al 1997 A Controlled Trial of Two Nucleoside Analogues Indinavir in Persons with HIV New England Journal of Medicine 337:725-733 

  83. Merck Ad for Crixivan (indinavir) Merck and Co, Inc. 1998 99-4084

  84. POZ magazine July 1999: Glaxo-Wellcome Ad for Ziagen (abacavir sulfate), December 1998 MG-001; Merck Ad for Crixivan (indinavir) Merck and Co, Inc. 1998 99-4084; Roxanne Ad for Viramune (nevirapine) July 1999, RX-2140 (4/98); Glaxo-Wellcome Ad for Combivir (lamivudine/zidovudine), March 1999; FDA Advisory (warning of spontaneous bleeding in 15 hemophiliacs using protease inhibitors), July 16 1996; Dube M, Johnson D, et al 1997 Protease Inhibitor Associated Hyperglycemia Lancet 350:713-4; Kotler D Truncal Obesity February 20 1998 Clinical Care Options for HIV (Monthly Experts Column); Garrett L The Virus at the End of the World Esquire March 1 1999; Lo J, et al 1998 Buffalo Hump in Men with HIV-1 Lancet March 21 1998 p867-870; Miller KD, et al Visceral Abdominal Fat Accumulation Associated with Use of Indinavir p871-875; Kim L FDA Approves Another Protease Inhibitor The Atlanta Journal and Constitution April 17 1999 p2E; Mickleburgh R, Study AIDS Drugs Long Term, Makers Told The Globe and Mail (Canada) May 4 1999; Colebunders E, et al Sexual Dysfunction with Protease Inhibitors Lancet 353 May 22 1999; Waldholz M, Tanouye E Cocktail Break Wall Street Journal January 25 1999

  85. James Curran on CNN, August 23 1998 8:00 pm EST

  86. Altman L New Cases Widen Views About AIDS New York Times January 5 1984

  87. Auberbach, et al 1984, Am J Med 76:487; Boffey P AIDS in the Future: Risk of Developing AIDS New York Times January 14 1986; JAMA 262: 3129-3130; Burkett E HIV: Not Guilty? Miami Herald December 23 1990 p12-17

  88. Eckholm E Onset of AIDS After Transfusion Found to Lag Average of 5 Years, New York Times May 29 1986; Lambrou E 1994 AIDS: Scare or Scam? Vantage Press, New York p15; Garrett L June 1999 Blacks May Have Genetic Risk of HIV Infection, Alive & Kicking!; Waldholz M, Tanouye E Cocktail Break Wall Street Journal January 25 1999

  89.  

  90. Johnson C, Philpott P Viral Load of Crap Reappraising AIDS Vol 4:10 October 1996; Duesberg P 1995 Nature 357 p197

  91. Rasnick D Kinetics Analysis of Consecutive HIV Proteolytic Cleavages of the Gag-Pol Polyprotein Journal of Biological Chemistry March 7 1997

  92. Mullis K October 1998 The Medical Establishment vs. The Truth Penthouse Magazine

  93. Rich J, et al 1999 Misdiagnosis of HIV Infection by HIV-1 Plasma Viral Load Testing: A Case Series Annals of Internal Medicine 130:37-39; Sullivan, et al Persistently Negative HIV-1 Antibody Enzyme Immunoassay Screening Results for Patients with HIV-1 Infection and AIDS AIDS January 14 1999 13:89-96

  94. Piatak M March 19 1993 High Levels of HIV-1 in Plasma During All Stages of Infection Determined by Competitive PCR Science 259:1749-53; Roehr B Loading Zone POZ Magazine August 1999 p76

  95. New England Journal of Medicine November 3 1994 331:18 p1176-1177

  96. Semba R, et al 1993 Increased Mortality Associated with Vitamin A Deficiency During HIV-1 Infection Arch Intern Med 153:2149-2154

  97. WHO/UNAIDS, 1998 HIV and Infant Feeding: A Guide for Health Care Managers and Supervisors FRH/Nut 98, 22

  98. HealthNews Mothering magazine Summer 1997 p40; Dew J October 8 1999 Newborn HIV Tests Criticized New Haven Register

  99. Farber C AZT Roulette: The Impossible Choices Facing HIV Positive Mothers Mothering magazine September/October 1998 Issue 90

  100. Semba R, et al 1993 Increased Mortality Associated with Vitamin A Deficiency During HIV-1 Infection Arch Intern Med 153:2149-2154

  101. Kumar R, et al 1994 Zidovudine Use in Pregnancy: A Report on 104 cases and Birth Defects Journal of AIDS 7(10):1034-1039

  102. Cordes R, et al 1995 Pitfalls in HIV Testing Postgraduate Medicine 98:177; Ng V, et al Serological Diagnosis with Recombinant Peptides/Proteins Clinical Chemistry 37:1667-1668; Profitt M, et al 1993 Laboratory Diagnosis of HIV Infection Inf Dis Clin North Am 7:203; Steckelberg J, Cockerill F 1988 Serologic Testing for HIV Antibodies Mayo Clinic Proc 63:373; Voevodi A 1992 HIV Screening in Russia Lancet 339:1548

  103. Mothering magazine Summer 1997 Health News p40

  104. Cleary, et al 1987 Journal of the American Medical Association 258(13):1757-62

  105. US Centers for Disease Control Recommendations of the US Public Heath Service Task Force on the Use of Zidovudine [AZT] to Reduce Perinatal Transmission of HIV Morbidity and Mortality Weekly Report Vol 43 No RR-11 August 5 1994

  106. Regush N No AZT For My Baby, Please http://ABCNews.com September 16 1999

  107. Gwarteny D Baby's Risk for HIV Sparks Fight The Oregonian January 31 1999; Wright J Court Grants Delay in Baby HIV Case The Register-Guard February 5 1999

  108. Good Morning America September 9 1998

  109. Philpott P Maine Mother Wins Court Fight Against HIV Doctors Reappraising AIDS Vol 6 October 10 1998

  110. Mother Wins Right to Stop HIV Drugs New York Times April 20 1999; Dateline NBC January 25, 1999; A Mother's Instinct People Magazine October 5 1998 p157-158

  111. News Broadcast, CJOB 68 August 18 1999; PeritzI Mother Fights to Block Son's HIV Drug Therapy The Globe and Mail (Canada) August 18 1999

  112. McKittrick A Ethical Drug Pricing: An Oxymoron? Provincetown Positive Spring 1999 p37-39

  113. Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington DC p 309-359

  114. Physicians Desk Reference 1994 p32

  115. Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington DC p 309-359

  116. Lauritsen J 1993 The AIDS War Askelpios, New York, FDA Documents Show Fraud in AZT Trials p381-397

  117. Lancet 1993 343:871, Concorde Coordinating Committee; Journal of the American Medical Association 1988 203:3009; New England Journal of Medicine 1992 326:437. Source: Hand T Why Antiviral Drugs Cannot Resolve AIDS Reappraising AIDS Vol 4:9 September 1996

  118. Source: Interview with Dr. Charles Thomas in video HIV=AIDS: Fact or Fraud? Starvision Productions (Stephen Allen, prod.) Denver CO; Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington DC p 309-359

  119. British Medical Journal July 15 1995 p156-158 (49%); Science Magazine February 24 1995 p1080 (34%); JAMA 260:3009 1988; New England Journal of Medicine 1992, 326:437. Source: Hand T Why Antiviral Drugs Cannot Resolve AIDS Reappraising AIDS Vol 4:9 September 1996

  120. Merck Manual 1992 16th edition p55, Merck Research Laboratories; Glaxo-Wellcome information sheet accompanying Zidovudine

  121. Hammer S, et al 1997 A Controlled Trial of Two Nucleoside Analogues Indinavir in Persons with HIV New England Journal of Medicine 337:725-733

  122. Merck ad for Crixivan A&U magazine July 1999 99-4084 910 (508) CRX

  123. Anderson M The Big Tease Valley Advocate February 20 1997

  124. Interview with Christine Maggiore September 1997

  125. AIDS expert Dr. Bruce Walker on ABC News Nightline May 19 1999 11:35 PM EST

  126. Ostrom N The New York Native July 15 1996 Issue 691

  127. POZ magazine July 1999: Glaxo-Wellcome Ad for Ziagen (abacavir sulfate), December 1998 MG-001; Merck Ad for Crixivan (indinavir) Merck and Co, Inc. 1998 99-4084; Roxanne Ad for Viramune (nevirapine) July 1999, RX-2140 (4/98); Glaxo-Wellcome Ad for Combivir (lamivudine/zidovudine) March 1999

  128. Journal of the American Medical Association July 10 1996

  129. Johnson H Rolling Stone Magazine Special Report: Dr. David Ho and the Lazarus Equation March 6 1997

  130. Levy J 1996 AIDS Surrogate Markers: Is There Truth in Numbers? JAMA Vol 276 p161-162

  131. Merck ad for Crixivan A&U magazine July 1999 99-4084 910 (508) CRX

  132. Altman L New York Times February 2 1996; Garrett L Newsday March 5 1996; The Boston Globe February 1 1999

  133. Dr. Raymond Schinazi of Emory University, Atlanta, Georgia. Source: Garrett L Newsday March 31 1995

  134. Lancet June 1 1997 Vol 349 p1745; Associated Press Report, Philadelphia Inquirer June 13 1997; Anderson M The Big Tease The Valley Advocate February 20 1997; Green F Cocktail Hangover Cleveland Free Times May 5 1999 Vol 7 Issue 33; Signorile M 641,086 and Counting Out magazine September 1998

  135. The Morning After POZ magazine February 1997

  136. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998; 9(2) Calculations: David Crowe, Alberta Reappraising AIDS Society; US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end 1997 p25 Figure 6

  137. US Centers for Disease Control HIV/AIDS Surveillance Report Year-end editions 1997, 1996, 1995, 1994, 1993 (AIDS indicator conditions reported by age group, US)

  138. Interview with Christine Maggiore September 1997 

  139. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998; 9(2) Calculations: David Crowe, Alberta Reappraising AIDS Society; US Centers for Disease Control 1998 HIV/AIDS Surveillance Report Year-end 1997 p25 Figure 6

  140. Gallo R 1984 Science 224; Piatak M 1993 Science 259; Ho D 1991 New England Journal of Medicine 324:961; Shaw G 1991 New England Journal of Medicine 324:954; Cooper 1992 Lancet 341:1099

  141. Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington DC p174-180

  142. Bialy H, Duesberg P March 1995 Letter to Nature. Source: AIDS: Virus or Drug Induced? Duesberg P (editor) 1996 Kluwer Academic Publishers, Netherlands

  143. Ho D, et al 1995 Rapid Turnover of Plasma Virions and CD4 Lymphocytes in HIV-1 Infection Nature 373:123-126; Wei X, et al 1995 Nature 373:117-122

  144. Kary Mullis at HEAL Los Angeles, October 25 1995

  145. Philpott P, Johnson C 1996 Viral Load of Crap Reappraising AIDS Vol 4:10 p2

  146. Johnson C Viral Load and the PCR Continuum Vol 4:4 November/ December 1996

  147. CDC faxback document #320320 sent in reply to an inquiry by Christine Johnson

  148. Roche Amplicor PCR Diagnostics HIV-1 Monitor test kit pamphlet

  149. Defer C, et al 1992 Multicenter Quality Control of PCR Detection of HIV DNA AIDS 6:659-663; Bush, et al 1992, Journal of AIDS 5:872; Gerberding J 1994 Incidence and Prevalence of HIV, Hepatitis B, and CMV Among Health Care Personnel at Risk for Blood Exposure Journal of Infectious Disease 170:1410-1417; de Mendoza, et al 1998 False Positive for HIV Using Commercial Viral Load Quantification Assays AIDS 12:2076-2077; Rich J, et al 1999 Misdiagnosis of HIV Infection by HIV-1 Plasma Viral Load Testing: A Case Series, Annals of Internal Medicine 130:37-39

  150. Schwartz D, et al 1997 Extensive Evaluation of a Seronegative Participant in an HIV-1 Vaccine Trial as a Result of False-Positive PCR, Lancet Vol 350 No 9073 p256

  151. Rasnick D 1997 Kinetics Analysis of Consecutive HIV Proteolytic Cleavages of the Gag-Pol Polyprotein Journal of Biological Chemistry March 7 p6348-6353

  152. Piatak M, et al 1993 Science 259:1749-53

  153. Roderer M 1998 Getting to the HAART of T Cell Dynamics Nature Medicine Vol 4:2 p145-146; Levy J 1996 AIDS Surrogate Markers: Is There Truth in Numbers? JAMA Vol 276 p161-162

  154. Levy J 1996 AIDS Surrogate Markers: Is There Truth in Numbers? JAMA Vol 276 p161-162

  155. Philpott P, Johnson C 1996 Viral Load of Crap Reappraising AIDS Vol 4:10 p2

  156. Papadopulos-Eleopulos E, et al 1988 Reappraisal of AIDS: Is the Oxidation Induced by the Risk Factors the Primary Cause? Medical Hypothesis 25:151-162

  157. Papadopulos-Eleopulos E, et al 1993 Is A Positive Western Blot Proof of HIV Infection? Bio/Technology 11:696-707; Papadopulos-Eleopulos E, et al 1996 The Isolation of HIV: Has it Really Been Achieved? Continuum Vol 4:3 Supplement p1-24; Turner V 1996 Do HIV Antibody Tests Prove HIV Infection? Continuum 1996 Vol 3:5 p8-11; Papadopulos-Eleopulos E, Stewart G, et al 1997 HIV Antibodies: Further Questions and a Plea for Clarification Current Medical Research and Opinion 13:627-634

  158. Philpott P 1997 The Isolation Question Reappraising AIDS Vol 5:6 June/July/August

  159. Gallo R 1984 Science 224:497-508; Piatak M 1993 Science 259:1749-1754; Piatak M 1993 Lancet 341:1099; Daar, et al 1991 New England Journal of Medicine 324[14]:961-964; Clark, et al 1991 New England Journal of Medicine 324:954-960; Cooper, et al 1992 Lancet 340:1257-1258

  160. Nature Magazine May 26 1994

  161. Morning Report Los Angeles Times May 16 1996 F-2

  162. Project Inform letter to Dr. Bruce Alberts, President of the National Academy of Sciences, July 31 1997: Endorsements are for signers as of August 20 1997

  163. Letter to Christine Maggiore from Ric Parish, PLUS Programs Manager, May 30 1997

  164. Anderson MK 1997 Sick of It All The Valley Advocate January 15 1998

  165. Farber C 1995 AIDS Inc.: Observations of an AIDS Dissident Provincetown Positive April/May Issue p14-18

  166. Garrett L The Virus at the End of The World Esquire magazine March 1999

  167. A&U America's AIDS Magazine June 1999 Issue 56

  168. Duesberg P 1987 Retroviruses as Carcinogens and Pathogens: Expectations and Reality Cancer Research 47:1199-1220

  169. Interview with Christine Maggiore August 25 1999

  170. Eichenwald K, Kolata G Drug Trials Hide Conflicts for Doctors New York Times May 16 1999

  171. Smith M, Sticking Point: AIDS Vaccine Designed by Don Francis in Final Testing San Francisco Weekly July 14 1999

  172. CNN Website Massive Trial of AIDS Vaccine to Begin in Thailand February 10 1999 8:27 pm EST

  173. Dissecting Room Lancet Vol 353 May 15 1999 p1719

  174. McGinley L Price of Success: Powerful Treatments Create Growing Rift Among AIDS Groups Wall Street Journal December 20 1996

  175. Drug Money Counter Punch magazine July 1 1998

  176. Farber C 1995 AIDS Inc.: Observations of an AIDS Dissident Provincetown Positive April/May Issue p14-18

  177. US Centers for Disease Control HIV/AIDS Surveillance Report Year-end editions through 1998

  178. WHO website http://hivinsite.ucsf.edu/social/un/2098.3ce6.html Ratios of estimated AIDS cases/reported AIDS cases for African countries with highest estimated AIDS cases: Angola 22/1; Congo 13/1; Ethiopia 55/1; Kenya 9/1; Madagascar 69/1; Mozambique 48/1; Nigeria 35/1; South Africa 33/1; Uganda 37/1; Zimbabwe 10/1. For all African countries (with available data) combined, the ratio of estimated AIDS cases to reported AIDS cases is 16/1

  179. CDC national AIDS advertising campaign, October 1987: 38 TV commercials, 8 radio spots, 6 print ads

  180. Bennett A, Sharpe A Health Hazard: AIDS Fight Skewed by Federal Campaign Exaggerating Risks Wall Street Journal May 1996 p1

  181. Philpott P CDC Releases Data for 1995: What HIV/AIDS Epidemic? Reappraising AIDS Vol 4:7 July 1996

  182. US Centers for Disease Control HIV/AIDS Surveillance Report Year-end editions 1993 through 1998 with one exception: AIDS in teenage boys rose from 238 in 1994 to 245 in 1995

  183. Laboratory Centre for Disease Control, Health Canada, 1998 HIV and AIDS in Canada: Surveillance Report to December 31 1997 p1

  184. Until There's a Cure advertisement http://www.until.org

  185. Interview with Patty Dwyer from Until There's A Cure September 3, 1999 (800) 888-UNTIL

  186. WHO website http://hivinsite.ucsf.edu/social/un/2098.3ce6.html Ratios of estimated AIDS cases/reported AIDS cases for African countries with highest estimated AIDS cases: Angola 22/1; Congo 13/1; Ethiopia 55/1; Kenya 9/1; Madagascar 69/1; Mozambique 48/1; Nigeria 35/1; South Africa 33/1; Uganda 37/1; Zimbabwe 10/1. For all African countries (with available data) combined, the ratio of estimated AIDS cases to reported AIDS cases is 16/1

  187. China Says HIV Cases Estimated at 400,000 April 1 1999 4:25 am EST Reuters, Bejing

  188. Merck Manual 1899 first edition

  189. Mendelsohn R 1984 How To Raise a Healthy Child In Spite of Your Doctor Ballentine Books, New York p13-15

  190. The American Medical Association Encyclopedia of Medicine Random House, New York p359; Mendelsohn R 1979 Confessions of a Medical Heretic Contemporary Publishing Company, Chicago p28-29

  191. The American Medical Association Encyclopedia of Medicine 1989 Random House, New York p 977

  192. Kono R 1975 The SMON Virus Theory Lancet ii:370-371; Shigematsu H, et al 1975 Epidemiological Approach to SMON Japanese Journal of Medicine, Science and Biology, 28 Supplement 23-33; Soda T 1980 Drug Induced Sufferings: Medical, Pharmaceutical and Legal Aspects Excerpta Medica: Amersterdam

  193. Marshall B Why Doctors Aren't Curing Ulcers Fortune Magazine June 9 1997

  194. Haney D Doctors Slow to Attack Bug Behind Ulcers Los Angeles Times (API) February 11 1996

  195. Marshall B Why Doctors Aren't Curing Ulcers Fortune Magazine June 9 1997

  196. NIAID and NIH Report 1996 The Relationship Between HIV and AIDS p3

  197. Giraldo R 1997 AIDS and Stressors Fundacion Arte y Cincia, Medellin; Root-Bernstein R 1993 Rethinking AIDS The Free Press, New York; Al Bayati A 1999 Get All the Facts: HIV Does Not Cause AIDS Toxi-Health, Dixon, CA

  198. Root-Bernstein R 1993 Rethinking AIDS The Free Press, New York p220-280; Brody S 1997 Sex at Risk Transaction Publishers, New Brunswick; Plumley P 1995 Condomania: Common Sense or Nonsense? HEAL Bulletin, HEAL New York

  199. Willner R 1994 Deadly Deception p30 Peltec Publishing; The Merck Manual 1992 Immuno-deficiency Diseases p303 Table 19-1 Merck Research Laboratories, Rahway; Fauci A, et al 1998 Principles of Internal Medicine, Edition 14 McGraw Hill, New York

  200. Chandra R 1983 Nutrition, Immunity and Infection Lancet i:688-69. Source: AIDS and Stressors; Merck Manual 1992 Immunodeficiency Diseases p317-318, Immunodeficiency and Malnutrition Merck Research Laboratories, Rahway; Chandra R 1975 Fetal Malnutrition and Postnatal Immunocompetence American Journal of Dis Chil 125:450-455. Source: AIDS and Stressors

  201. Merck Manual 1992 Immunodeficiency Diseases, p304 Table 19-2 Immunosuppressive Agents Merck Research Laboratories, Rahway; Heyer A 1983 Introduction to Nutrition Keats Publishing, New Canaan p2-12; Owen B 1995 You Don't Have to Die Sick Adrenal Exhaustion p43-46 Health Hope Publishing House, Cannon Beach

  202. The American Medical Association Encyclopedia of Medicine 1989 Random House, New York p258

  203. Niwa Y, Yokoyama M 1981 Effect of Glucocorti-costeroid Therapy on the Immune System of Patients with Nonimmunologically Mediated Dermatose J Clin Lab Immunol 6(2):147-155; Parrillo J, Fauci A 1978 Mechanisms of Corticosteroid Action on Lymphocyte Subpopulations of Effector Cells Mediating Cellular Toxicity in Man Clin Exp Immunol 31:116-125; Fauci A. Dale D, Balow J 1976 Glucocorticosteroid Therapy: Mechanisms of Action and Clinical Considerations Annals of Internal Medicine 84:304-15; Leung F, Fam A, Osoba D 1981 Kaposi's Sarcoma Complicating Corticosteroid Therapy for Temporal Arteritis The American Journal of Medicine 71(2):320-322

  204. Merck Manual 1992 Anti-Infective Drugs: Sulfonamides p46-48 Merck Research Laboratories, Rahway; Drugs Facts and Comparisons 1999 Facts and Comparisons Publishing, St. Louis (800) 223-0554

  205. Duesberg P 1996 Inventing The AIDS Virus Regnery Publishing, Washington DC p300

  206. Merck Manual 1992 Anti-Infective Drugs: Sulfonamides p46-48 Merck Research Laboratories, Rahway; Drugs Facts and Comparisons 1999 Facts and Comparisons Publishing, St. Louis (800) 223-0554

  207. Bull Mem Soc Med Hopitaux de Paris, 3rd Ser 1909, 28:958-996; Pharmacology Ther 1992 55: 201-207

  208. Immune System Toxins Rachel's Environment and Health Weekly #536 March 6 1997; Statement on Immune Toxins #544 May 1 1997 Environmental Research Foundation, Annapolis

  209. Hebert C, Brecher M, et al Fewer Blood Transfusions Save Lives New England Journal of Medicine February 1999; United Press International, February 10 1999; Ward, et al 1989 The Natural History of Transfusion Associated Infection With HIV New England Journal of Medicine 321:947-952

  210. Benson H 1997 The Nocebo Effect: History and Physiology Preventive Medicine 26:612-615; Binik Y 1985 Psychosocial Predictors of Sudden Death: A Review and Critique Social Science Medicine 20(7):667-80; Cecchi R 1984 Stress: Prodrome to Immune Deficiency Annals of the New York Academy of Sciences 437:286-289; Cohen S 1988 Voodoo Death, the Stress Response, and AIDS Advanced Biochem Psychopharmacology 44:95-109; Golden K Voodoo in Africa and the United States December 1977 American Journal of Psychiatry 134 (12):1425-1427; Uno H, et al 1989 Hippocampal Damage Associated with Prolonged and Fatal Stress in Primates Journal of Neuroscience 9(5):1705-1711; Milton G Self-Willed Death or the Bone Pointing Syndrome June 23 1973 Lancet 1:1435-1436

  211. Guyton A, Hall J 1996 Textbook of Medical Physiology Sanders, New York p964-965

  212. Cohan J Legally Speaking, Mason v Jacobs 4Front Magazine April 30 1997

  213. Cannon W 1957 Voodoo Death Psychosomatic Medicine 19:182-190 (reprinted from American Anthropologist 44:1942); Campinha-Bacote J 1992 Voodoo Illness Perspectives in Psychiatric Care 28(1):11-17

  214. The American Medical Association Encyclopedia of Medicine 1989 Random House, New York p798

  215. Reuters News Service report, May 14 1998 on Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT), University of Toronto, Canada

  216. Giraldo R 1997 AIDS and Stressors Fundacion Arte y Cincia, Medellin; Root-Bernstein R 1993 Rethinking AIDS The Free Press, New York; Al Bayati A 1999 Get All the Facts: HIV Does Not Cause AIDS Toxi-Health, Dixon, CA

  217. Jagge, et al 1983 Annals of Internal Medicine 99:145-151

  218. Osterloh J, et al 1984 Butyl Nitrite Transformation Invitro Anal Toxicology 8:164-169; Haverkos H, et al 1985 Disease Manifestation Among Homosexual Men with AIDS Sexually Transmitted Diseases 12:203-208; Root-Bernstein R 1990 Do We Know the Cause(s) of AIDS? Pesp Biol Med 33:480-500

  219. Krieger L Kaposi's Sarcoma, AIDS Link Questioned, San Francisco Examiner June 5 1992 pA-1,A-17; US Centers for Disease Control HIV/AIDS Surveillance Report Year-end reports 1993-1998

  220. Marmor, Lancet May 15 1982 (100%); Jaffe, Annals of Internal Medicine 1983 (96%); Harverkos, STD Oct/Nov 1985 (97%); Kaslow, Journal of the American Medical Association 261:23 1989 (96%) Archibald, Epidemiology 3:203 (100%); Duesberg, Genetica, February 1995 (93%)

  221. Yardley J, et al 1980 Immunologic Status in Patients with Giardiasis, Gastroenterology 78: 421-422; Jaffe, et al 1983 Annals of Internal Medicine 99:145-151

  222. Bozzette S, et al 1990 A Controlled Trial of Early Adjunctive Treatment with Corticosteroids for PCP Pneumonia in AIDS New England Journal of Medicine 323 (21):145-7; Traltner A, et al 1993 The Appearance of Kaposi's Sarcoma During Corticosteroid Therapy Cancer 72 (5):1779-1783

  223. Average of two random issues of Edge magazine and Frontiers Gay Biweekly magazine less classified, phone sex, theater and cinema advertisements

  224. Merck Manual 1992 16th edition p55, Merck Research Laboratories; Glaxo-Wellcome information sheet accompanying Zidovudine

  225. Ascher M, et al 1993 Does Drug Use Cause AIDS? Nature 362:103-104; Schecter M, et al 1993 HIV-1 and the Aetiology of AIDS Lancet 341:658-659; Duesberg P 1993 Can Epidemiology Determine Whether Drugs or HIV Cause AIDS? AIDS Forshung 12:627-635

  226. Brody, S 1997 Sex at Risk Transaction Publishers, New Brunswick; 80%: Potterat et al 1987 JAMA 256 p 12; 65%: Renzullo et al 1990 JAIDS 3, p266-271; 83%-90%: Committee on AIDS Research and the Behavioral, Social, and Statistical Sciences 1989; 69%: Chicago Dept of Public Health, Journal of AIDS 1997; 99.4%: NYC Dept of Health, American Journal of Epidemiology 137:2

  227. Duesberg P, Rasnick D 1998 The AIDS Dilemma: Drug Diseases Based on a Passenger Virus, Genetica 104: p109 Table 7

  228. Achard G, Bernard H, et al 1909 Action de la Morphine sur les Proprietes Leucocytaires; Leucodiagnostic du Morphinisme Bulletin et Memoires de la Societe Medicale des Hopitaux de Paris 28, 3rd Series:958-966; Terry C, Pellens M 1928 The Opium Problem Bureau of Social Hygiene of New York; Briggs J, McKerron C, et al 1967 Severe Systemic Infection Complicating "Mainline" Heroin Addiction Lancet ii:1227-1231; Sapira J 1968 The Narcotic Addict as a Medical Patient Am J Med 45:555-558; Harris P, Garret R 1972 Susceptibility of Addicts to Infection and Neoplasia New Engl J Med 287:310; Geller S, Stimmel B 1973 Diagnostic Confusion from Lymphatic Lesions in Heroin Addicts Ann Intern Med 78:703-705; Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing 73:2105-2109; Brown S, Stimmel B, et al 1974 Immunologic Dysfunction in Heroin Addicts Arch Intern Med 134:1001-1006; Louria D 1974 Infectious Complications of Nonalcoholic Drug Abuse Annu Rev Med 25:219-231; McDonough R, Madden J, et al 1980 Alteration of T and Null Lymphocyte Frequencies in the Peripheral Blood of Human Opiate Addicts: In Vivo Evidence of Opiate Receptor Sites on T Lymphocytes J Immunol 125:2539-2543; Gottlieb M, Schanker H, et al 1981 Pneumocystis PneumoniaLos Angeles Morbidity and Mortality Weekly Reports 30:250-252; Marmor M, Friedman-Kien A, et al 1982 Risk Factors for Kaposi's Sarcoma in Homosexual Men Lancet i:1083-1087; Jaffe H, Choi K, et al 1983 National Case-Control Study of Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in Homosexual Men: Part 1, Epidemiological Results Ann Intern Med 99:145-151; Tubaro E, Borelli G, et al 1983 Effect of Morphine on Resistance to Infection J Infect Dis 148:656-666; Layon J, Idris A, et al 1984 Altered T Lymphocyte Subsets in Hospitalized Intravenous Drug Abusers Arch Intern Med 144:1376-1380; Newell G, Mansell P, et al 1985a Volatile Nitrites: Use and Adverse Effects Related to the Current Epidemic of Acquired Immune Deficiency Syndrome Am J Med 78:811-816; Newell G, Mansell P, et al 1985b Risk Factor Analysis Among Men Referred for Possible Acquired Immune Deficiency Syndrome Preventive Med 14:81-91; Culver K, Ammann A, et al 1987 Lymphocyte Abnormalities in Infants Born to Drug-Abusing Mothers J Pediatr 111:230-235; Donahoe R, Bueso-Ramos C, et al 1987 Mechanistic Implications of the Findings that Opiates and Other Drugs of Abuse Moderate T-cell Surface Receptors and Antigenic Markers Ann N.Y. Acad Sci 496:711-721; Bureau of Justice Statistics 1988 Special ReportDrug Law Violators, 1980-1986 US Department of Justice, Washington DC; Haverkos H, Dougherty J (eds) 1988b Health Hazards of Nitrite Inhalants US Department of Health and Human Services, Washington DC; Selwyn P, Feingold A, et al 1988 Increased Risk of Bacterial Pneumonia in HIV-Infected Intravenous Drug Users without AIDS AIDS 2:267-272; Novick O, Ochshorn M, et al 1989 Natural Killer Cell Activity and Lymphocyte Subsets in Parenteral Heroin Abusers and Long-Term Methadone Maintenance Patients The Journal of Pharmacology and Experimental Therapeutics 250:606-610; Mientjes G, Miedema F, et al 1991 Frequent Injecting Impairs Lymphocyte Reactivity in HIV-Positive and HIV-Negative Drug Users AIDS 5:35-41; Pillai R, Nair B, et al 1991 AIDS, Drugs of Abuse and the Immune System: A Complex Immunotoxicological Network Arch Toxicol 65:609-617; Larrat P, Zierler S 1993 Entangled Epidemics: Cocaine Use and HIV Disease J Psychoactive Drugs 25:207-221; Mientjes G, van Ameijden E, et al 1993 Clinical Symptoms Associated with Seroconversion for HIV-1 among Misusers of Intravenous Drugs: Comparison with Homosexual Seroconverters and Infected and Non-Infected Intravenous Drug Misusers Br. Med. J. 306:371-373; Sadownick D 1994 Kneeling at the Crystal Cathedral Genre December/January 1994 p40-45, 86-90; Ratajczak H, Thomas P, et al 1995 Local Versus Systemic Immunotoxicity of Isobutyl Nitrite Following Subchronic Inhalation Exposure of Female B6C3F1 Mice Fundamental and Applied Technology 27:177-184; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  229. Jaffe H, Choi K, et al 1983 National Case-Control Study of Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in Homosexual Men: Part 1, Epidemiological Results Ann Intern Med 99:145-151; Newell G, Adamas S, et al 1984 Toxicity, Immunosuppressive Effects and Carcinogenic Potential of Volatile Nitrites: Possible Relationship to Kaposi's Sarcoma Pharmacotherapy 4:284-291; Haverkos H, Pinsky P, et al 1985 Disease Manifestation Among Homosexual Men with Acquired Immunodeficiency Syndrome: A Possible Role of Nitrites in Kaposi's Sarcoma J Sex Trans Dis 12:203-208; Haverkos H, Kaposi's Sarcoma and Nitrite Inhalants In: Psychological, Neuropsychiatric and Substance Abuse Aspects of AIDS by Bridge T, Heather H, Johnson M (eds) Raven Press, New York p165-172; Haverkos H, Dougherty J 1988a Health Hazards of Nitrite Inhalants Am J Med 84:479-482; Archer C, Spittle M, et al 1989 Kaposi's Sarcoma in a Homosexual10 Years On Clin Exper Dermatol 14:233-236; Friedman-Kien A, Saltzman B, et al 1990 Kaposi's Sarcoma in HIV-Negative Homosexual Men Lancet 335:168-169; Marquart K, Engst R, et al 1991 An 8-Year History of Kaposi's Sarcoma in an HIV-Negative Bisexual Man AIDS 5:346-348; Safai B, Peralta H, et al 1991 Kaposi's Sarcoma among HIV-Negative High Risk Populations VII International Conference on AIDS, Florence, Italy

  230. Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing 73:2105-2109; Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of Severe HIV-1-Related Disease in Intravenous Drug Users in New York City Science 242:916-919; Rogers M, Ou C, et al 1989 Use of the Polymerase Chain Reaction for Early Detection of the Proviral Sequences of Human Immunodeficiency Virus in Infants Born to Seropositive Mothers N Engl J Med 320:1649-1654

  231. Gottlieb M, Schanker H, et al 1981 Pneumocystis PneumoniaLos Angeles Morbidity and Mortality Weekly Reports 30:250-252; Jaffe H, Choi K, et al 1983 National Case-Control Study of Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in Homosexual Men: Part 1, Epidemiological Results Ann Intern Med 99:145-151; Mathur-Wagh U, Enlow R, et al 1984 Longitudinal Study of Persistent Generalized Lymphadenopathy in Homosexual Men: Relation to Acquired Immunodeficiency Syndrome Lancet i:1033-1038; Mathur-Wagh U, Mildvan D, et al 1985 Follow-Up of 41/2 Years on Homosexual Men with Generalized Lymphadenopathy N Engl J Med 313:1542-1543; Selwyn P, Feingold A, et al 1988 Increased Risk of Bacterial Pneumonia in HIV-Infected Intravenous Drug Users without AIDS AIDS 2:267-

  232. Geller S, Stimmel B 1973 Diagnostic Confusion from Lymphatic Lesions in Heroin Addicts Ann Intern Med 78:703-705; Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing 73:2105-2109; Espinoza P, Bouchard I, et al 1987 High Prevalence of Infection by Hepatitis B Virus and HIV in Incarcerated French Drug Addicts Gastroenterologie Clinique et Biologique 11:288-292; Des Jarlais D, Friedman S, et al 1988 Risk Reduction of the Acquired Immune Deficiency Syndrome among Intravenous Drug Users In: AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B, Baker L (eds) National Health Publishing, Owings Mills, MD p97-109; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  233. Firooznia H, Seliger G, et al 1973 Disseminated Extrapulmonary Tuberculosis in Association with Heroin Addiction Radiology 109:291-296; Courtwright D 1982 Dark Paradise: Opiate Addiction in America Before 1940 Harvard University Press, Cambridge, MA; Layon J, Idris A, et al 1984 Altered T Lymphocyte Subsets in Hospitalized Intravenous Drug Abusers Arch Intern Med 144:1376-1380; Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of Severe HIV-1-Related Disease in Intravenous Drug Users in New York City Science 242:916-919; Braun M, Truman B, et al 1989 Increasing Incidence of Tuberculosis in a Prison Inmate Population, Associated with HIV Infection J Am Med Assoc 261:393-397; Brudney K, Dobkin J 1991 Resurgent Tuberculosis in New York City Am Rev Respir Dis 144:744-749; Hayes T, Altman R, et al 1994 HIV-Related Deaths from Selected Infectious Diseases among Persons without AIDS in New Jersey Journal of Acquired Immune Deficiency Syndromes 7:1074-1078

  234. Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing 73:2105-2109; Des Jarlais D, Friedman S, et al1988 Risk Reduction of the Acquired Immune Deficiency Syndrome among Intravenous Drug Users In: AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B, Baker L (eds) National Health Publishing, Owings Mills, MD p97-109; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165; Bergling T 1997 All Methed Up: Doing Crystal Meth Will Lift You Up Until You Break Genre 53:October p45-47,88; McEvoy A, Kitchen N, et al 1998 Intracerebral Haemorrhage Caused by Drug Abuse Lancet 351:1029

  235. Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of Severe HIV-1-Related Disease in Intravenous Drug Users in New York City Science 242:916-919; Koch T July 30 1990 Uninfected Children of HIV-Infected Mothers May Still Suffer Nervous Problems CDC AIDS Weekly p9; Aylward E, Butz A, et al 1992 Cognitive and Motor Development in Infants at Risk for Human Immunodeficiency Virus Am J Dis Child 146:218-222; Larrat P, Zierler S 1993 Entangled Epidemics: Cocaine Use and HIV Disease J Psychoactive Drugs 25:207-221; Hayes T, Altman R, et al 1994 HIV-Related Deaths from Selected Infectious Diseases among Persons without AIDS in New Jersey Journal of Acquired Immune Deficiency Syndromes 7:1074-1078; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165; McEvoy A, Kitchen N, et al 1998 Intracerebral Haemorrhage Caused by Drug Abuse Lancet 351:1029

  236. Des Jarlais D, Friedman S, et al 1988 Risk Reduction of the Acquired Immune Deficiency Syndrome among Intravenous Drug Users In: AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B, Baker L (eds) National Health Publishing, Owings Mills, MD p97-109; Muñoz A, Vlahov D, et al 1992 Prognostic Indicators for Development of AIDS among Intravenous Drug Users J Acquir Immune Defic Syndr 5:694-700; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  237. Des Jarlais D, Friedman S, et al 1988 Risk Reduction of the Acquired Immune Deficiency Syndrome among Intravenous Drug Users In: AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B, Baker L (eds) National Health Publishing, Owings Mills, MD p97-109; Ettinger N, Albin R 1989 A Review of the Respiratory Effects of Smoking Cocaine Am J Med 87:664-668; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  238. Savona S, Nardi M, et al 1985 Thrombocytopenic Purpura in Narcotics Addicts Ann Intern Med 102:737-741

  239. Fricker H, Segal S 1978 Narcotic Addiction, Pregnancy, and the Newborn Am J Dis Child 132:360-366; Lifschitz M, Wilson G, et al 1983 Fetal and Postnatal growth of Children Born to Narcotic-Dependent Women J Pediatr 102:686-691; Alroomi L, Davidson J, et al 1988 Maternal Narcotic Abuse and the Newborn Arch Dis Child 63:81-83; Rogers M, Ou C, et al 1989 Use of the Polymerase Chain Reaction for Early Detection of the Proviral Sequences of Human Immunodeficiency Virus in Infants Born to Seropositive Mothers N Engl J Med 320:1649-1654; Toufexis A May 13 1991 Innocent Victims Time p56-60; Finnegan L, Mellot J, et al 1992 Perinatal Exposure to Cocaine: Human Studies In: Cocaine: Pharmacology, Physiology and Clinical Strategies by Lakoski J, Galloway M, White F (eds) CRC Press, Boca Raton, FL p391-409; Larrat P, Zierler S 1993 Entangled Epidemics: Cocaine Use and HIV Disease J Psychoactive Drugs 25:207-221

  240. Des Jarlais D, Friedman S, et al 1988 Risk Reduction of the Acquired Immune Deficiency Syndrome among Intravenous Drug Users In: AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B, Baker L (eds) National Health Publishing, Owings Mills, MD p97-109; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  241. Larrat P, Zierler S 1993 Entangled Epidemics: Cocaine Use and HIV Disease J Psychoactive Drugs 25:207-221; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  242. Wilson J, Kalasinsky K, et al 1996 Striatal Dopamine Nerve Terminal Markers in Human, Chronic Methamphetamine Users Nature Medicine 2:699-703

  243. Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing 73:2105-2109

  244. Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing 73:2105-2109; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  245. Dismukes W, Karchmer A, et al 1968 Viral Hepatitis Associated with Illicit Parenteral Use of Drugs J Am Med Assoc 206:1048-1052; Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing 73:2105-2109; Layon J, Idris A, et al 1984 Altered T Lymphocyte Subsets in Hospitalized Intravenous Drug Abusers Arch Intern Med 144:1376-1380

  246. Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  247. Layon J, Idris A, et al 1984 Altered T Lymphocyte Subsets in Hospitalized Intravenous Drug Abusers Arch Intern Med 144:1376-1380; Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of Severe HIV-1-Related Disease in Intravenous Drug Users in New York City Science 242:916-919; Mientjes G, van Ameijden E, et al 1993 Clinical Symptoms Associated with Seroconversion for HIV-1 among Misusers of Intravenous Drugs: Comparison with Homosexual Seroconverters and Infected and Non-Infected Intravenous Drug Misusers Br. Med. J. 306:371-373; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165

  248. Indiana Hemophilia Foundation. Source: Duesberg P 1996 Inventing the AIDS Virus Regnery Publishing, Washington DC p287-288

  249.  

  250. Blood Transfusions: Fewer Blood Transfusions Save Lives United Press International February 10 1999; Hebert P, et al New England Journal of Medicine February 11 1999

  251. Brody, S 1997 Sex at Risk Transaction Publishers, New Brunswick; 80%: Potterat et al 1987 JAMA 256 p 12; 65%: Renzullo, et al 1990 JAIDS 3, p266-271; 83%-90%: Committee on AIDS Research and the Behavioral, Social, and Statistical Sciences 1989; 69%: Chicago Dept of Public Health, Journal of AIDS 1997; 99.4%: NYC Dept of Health, American Journal of Epidemiology 137:2

  252. Fumento M Washington Times June 8 1999

  253. US Centers for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998 p14 Table 5

  254. Altman L Outside of US and Europe HIV Transmission is Through Heterosexual Contact New York Times November 2 1993

  255. Biggar R, et al 1985 ELISA HTLV Retrovirus Antibody Reactivity Associated With Malaria Lancet ii 520-543; Charmot G, Simon F 1990 HIV Infection and Malaria Revue Du Practien 40:2124; Bush, et al Journal of AIDS 5:872 1992; Kashala O, et al 1994 Infection with HIV-1 and Human T Cell Lymhotropic Viruses Among Leprosy Patients and Contacts Journal of Infectious Diseases 169:292-304

  256. Piatak M, et al 1993 Science 259:1749-53 

  257. World Health Organization annual conversions rates. Source: Willner R Deadly Deception Peltec Publishing p39-41

  258. Benthen B, et al Insights from the Tricontinental Seroconverter Study AIDS June 18 1998 12:1039-1045; New England Journal of Medicine 1995 332:209; Journal of Infectious Diseases 1996 173:60

  259. Buchbinder S, et al 1994 Long Term HIV 1 Infection Without Immunologic Progression AIDS 8:1123; Pantaleo G, et al 1995 Studies in Subjects with Long-Term Non-Progressive HIV Infection New England Journal of Medicine 332(4):209-216; Muñoz A, et al 1995 Long-Term Survivors of HIV-1 Infection Journal of AIDS and Human Retrovirology April 15 8(5):496-505

  260. Journal InterAM Medical Health Association 1992 1:1-8

  261. Callen M Surviving AIDS Harper-Collins Publishing; Root-Bernstein R Rethinking AIDS The Free Press, New York p361-363; Time Magazine March 22 1993; Gregory S, Leonardo B 1992 They Conquered AIDS: True Life Adventures; MacIntyre R, Mortal Men: Living with Asymptomatic HIV University Press, Rutgers; Chaitow L, Strohecker J 1997 You Don't Have to Die: Unraveling the AIDS Myth Future Medicine Publishing

  262. Genetica 1996 AIDS: Virus or Drug Induced? p3-22; Ostrom N The T4 Myth New York Native May 2 1994

  263. Bird A 1996 Non-HIV AIDS Journal of Antimicrobial Chemotherapy 37(B):171-183; Haynes S California State Department of Health Services AIDS Study. Source: Farber C SPIN magazine May 1994

  264. Mosley J Transfusion Safety Study Group Report presented at 1993 International AIDS conference. Source: Farber C SPIN magazine May 1994

  265. Fleming T, De Mets D Surrogate End Points in Clinical Trials: Are We Being Misled? Annals of Internal Medicine October 1 1996 125:605-613

  266. Carney W, Rubin R, et al Analysis of T Lymphocyte Subsets in CMV Mononucleosis June 1981 Journal of Immunology; Feeney C, Bryzman S, et al October 1995 T-Lymphocyte Subsets in Acute Illness Critical Care Medicine 23 (10):1680-1685

  267. US Centers for Disease Control, 1998 Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

  268. Source for entire section: The American Association of Oriental Medicine Understanding Oriental Medicine, Acupuncture and Herbology Catasauqua, PA; Cassileth B PhD The Alternative Medicine Handbook WW Norton & Co, New York; The Complete Guide to Alternative And Conventional Treatments Time Life Books, Alexandria; Mortimore D The Complete Illustrated Guide to Nutritional Healing, Element Press, Boston; New Choices in Natural Healing, Rodale Press Inc., Emmaus; Tips J PhD Your Liver...Your Lifeline: Detoxification and Rejuvenation for the Whole Body Apple-A-Day Press, Austin; Jensen B PhD DC Tissue Cleansing Through Bowel Management Bernard Jensen International, Escondido

  269. POZ Magazine July 1992

  270. Schwartz D, et al 1997 Extensive Evaluation of a Seronegative Participant in an HIV-1 Vaccine Trial as a Result of False-Positive PCR, Lancet Vol 350 No 9073 p256

  271. Wall Street Journal May 1 1996

  272. American Heritage Dictionary Second College Edition Houghton Mittlin Company, Boston p492

  273. Documentary film HIV=AIDS: Fact or Fraud Starvision Productions Denver CO 1997; CNN Website Massive Trial of AIDS Vaccine to Begin in Thailand February 10 1999 8:27 pm EST

  274. Altman L Inherited Factor May Play Role in Risk of AIDS New York Times May 10 1987

  275. Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of Severe HIV-1-Related Disease in Intravenous Drug Users in New York City Science 242:916-919; Ettinger N, Albin R 1989 A Review of the Respiratory Effects of Smoking Cocaine Am J Med 87:664-668; Mientjes G, van Ameijden E, et al 1993 Clinical Symptoms Associated with Seroconversion for HIV-1 among Misusers of Intravenous Drugs: Comparison with Homosexual Seroconverters and Infected and Non-Infected Intravenous Drug Misusers Br. Med. J. 306:371-373; Hayes T, Altman R, et al 1994 HIV-Related Deaths from Selected Infectious Diseases among Persons without AIDS in New Jersey Journal of Acquired Immune Deficiency Syndromes 7:1074-1078; Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to HIV Int J STD & AIDS 7:151-165 

  • No labels